Portfolio company
Novadip Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
6 investors
Sectors
About
This company develops regenerative tissue products to treat patients with large bone defects, non-union fractures and spinal fusion requirements.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Novadip
This company develops regenerative tissue products to treat large bone defects and spinal fusion for patients with limited treatment options.
EpiBone
This company grows personalized bone and cartilage grafts from a patient's own stem cells to treat individuals with skeletal defects.
Kuros Biosciences
This company develops bone graft technologies and orthobiologics for surgeons and hospitals to facilitate bone healing and tissue regeneration.
IBI
This company develops and manufactures biomimetic bone substitutes for orthopaedic and dental surgeons to support bone tissue regeneration.
Bonesupport
This company develops and manufactures injectable bioceramic bone graft substitutes for surgeons and healthcare providers to treat bone voids, defects and infections.
BE Therapeutics
This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.
Ossium Health
This company develops bone marrow-derived cell therapies and bone allografts for healthcare providers, life science companies and researchers treating blood and immune diseases.
NovaGo Therapeutics
This clinical-stage biotechnology company develops human antibody therapeutics to promote nerve regeneration for patients with spinal cord injuries and strokes.
